Molecular Modeling and Drug Development
Howida A. Elseedy, Caroline Joseph Kiriacos, Triveena M. Ramsis · 2024
Due to the utilization of conventional methods for drug design, the process of developing new drugs has been rigorous and time-consuming. In silico drug design offers a green way to design and develop drugs by avoiding many laboratory assays and chemicals, which is an important extra benefit that should not be neglected. The key in silico drug design methodologies include Ligand-Based Drug Design (LBDD), Structure-Based Drug Design (SBDD), homology modeling, and in silico pharmacokinetics. In silico drug design offers a green approach to design and develop drugs by avoiding many laboratory assays and chemicals. This can help minimize the time and cost associated with drug development by offering a more effective way to assess novel drugs before they are evaluated in clinical trials.